Dr. Reddy's Laboratories Limited (RDY)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 23, 2026
Consensus estimate row
EPS target
$0.10
Street estimate
Revenue target
$843.5M
Street estimate
Trailing EPS (avg 4Q)
$0.06
Beat rate last 4: 0%
Latest EPS YoY
-70.0%
vs 2025-07-23
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$812.4M
Printed quarters
EPS beat rate (4Q)
0%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 22, 2026
EPS miss
EPS actual / est
$0.06 / $0.09
-34.6%
Revenue actual / est
— / $850.6M
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/23/2026upcoming | $0.10 | Pending | — | $843.5M | Pending | — |
| 7/22/2026 | $0.09 | $0.06 | -34.6% | $850.6M | Pending | — |
| 7/21/2026 | $0.09 | $0.06 | -34.6% | $850.6M | $835.7M | -1.7% |
| 5/13/2026 | $0.09 | $0.06 | -33.3% | $869.9M | Pending | — |
| 5/12/2026 | $0.09 | $0.06 | -33.3% | $886.6M | $789.1M | -11.0% |
| 5/11/2026 | $0.09 | $0.06 | -33.3% | $886.6M | $785.9M | -11.4% |
| 1/20/2026 | $0.16 | $0.16 | 0.0% | $927.7M | $951.6M | +2.6% |
| 10/24/2025 | $0.18 | $0.19 | +5.6% | $979.8M | $1.00B | +2.3% |
| 7/23/2025 | $0.18 | $0.20 | +11.1% | $1.01B | $988.9M | -2.6% |
| 5/9/2025 | $0.20 | $0.22 | +10.0% | $978.2M | $996.2M | +1.8% |
| 1/29/2025 | $0.19 | $0.20 | +5.3% | $975.7M | $969.6M | -0.6% |
| 11/5/2024 | $0.21 | $0.04 | -80.6% | $909.2M | $954.3M | +5.0% |
| 7/27/2024 | $0.19 | $0.20 | +4.0% | $869.8M | $920.7M | +5.9% |
| 5/7/2024 | $0.17 | $0.19 | +11.8% | $847.6M | $848.1M | +0.1% |
| 1/31/2024 | $0.17 | $0.20 | +17.6% | $833.4M | $868.0M | +4.2% |
| 10/27/2023 | $0.18 | $0.21 | +16.7% | $816.2M | $826.4M | +1.3% |
| 7/26/2023 | $0.14 | $0.21 | +50.0% | $777.8M | $822.4M | +5.7% |
| 5/10/2023 | $0.11 | $0.14 | +27.3% | $745.2M | $767.0M | +2.9% |
| 1/25/2023 | $0.12 | $0.18 | +50.0% | $729.1M | $829.8M | +13.8% |
| 10/28/2022 | $0.12 | $0.16 | +33.3% | $695.5M | $764.6M | +9.9% |
| 7/28/2022 | $0.12 | $0.90 | +645.8% | $679.2M | $653.9M | -3.7% |
| 5/19/2022 | $0.51 | $0.11 | -78.4% | $678.7M | $699.4M | +3.0% |
| 1/28/2022 | $0.64 | $0.11 | -82.7% | $732.8M | $708.9M | -3.3% |
Need RDY data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.